Literature DB >> 3096946

Increased lung vascular permeability after arachidonic acid and hydrostatic challenge.

W Seeger, D Walmrath, M Menger, H Neuhof.   

Abstract

Arachidonic acid (AA) metabolites are known to be potent vasoactive substances in the pulmonary circulation, whereas their influence on lung vascular permeability is still uncertain. We investigated the effect of AA bolus injection on the capillary filtration coefficient (Kf,C) of isolated rabbit lungs, recirculatingly perfused with Krebs-Henseleit albumin (1%) buffer. Kf,C was measured using repetitive sudden venous pressure elevations (7.5 Torr) and time zero extrapolation of the slope of the weight gain curve. It ranged from 1.3 to 2.4 cm3 X s-1 X Torr-1 X g-1 X 10(-4) in control lungs. Pulmonary arterial injection of AA (100 microM; in presence of 20 microM indomethacin to suppress pulmonary arterial pressure rise) during an acute hydrostatic challenge, but not at zero venous pressure, caused a greater than 10-fold increase in Kf,C. Vascular compliance was not altered. Additional experiments, performed under zero-flow conditions to avoid any ambiguity in microvascular pressure, corroborated the severalfold increase in vascular permeability, detectable within 3 min after AA application during acute hydrostatic challenge.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096946     DOI: 10.1152/jappl.1986.61.5.1781

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  12 in total

1.  Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.

Authors:  W Seeger; F Grimminger; M Barden; G Becker; J Lohmeyer; D Heinrich; H G Lasch
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Streptococcal pyrogenic exotoxin F (SpeF) causes permeabilization of lung blood vessels.

Authors:  M Matsumoto; N Ishikawa; M Saito; K Shibayama; T Horii; K Sato; M Ohta
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Permeability of the endothelium and partitioning of the pulmonary blood flow resistance in isolated perfused pig lungs: effects of breed and age.

Authors:  P Gustin; B Urbain; A Delaunois; K Zeimes; M Ansay
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

4.  Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.

Authors:  W L Salzer; C E McCall
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  F Grimminger; D Walmrath; R G Birkemeyer; S Bhakdi; W Seeger
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

6.  Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  W Seeger; H Walter; N Suttorp; M Muhly; S Bhakdi
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs.

Authors:  J Schmeck; T Koch; B Patt; A Heller; H Neuhof; K van Ackern
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

8.  Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction.

Authors:  Farzaneh Ketabchi; Hossein A Ghofrani; Ralph T Schermuly; Werner Seeger; Friedrich Grimminger; Bakytbek Egemnazarov; S Mostafa Shid-Moosavi; Gholam A Dehghani; Norbert Weissmann; Natascha Sommer
Journal:  Respir Res       Date:  2012-01-31

9.  Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.

Authors:  F Grimminger; M Thomas; R Obernitz; D Walmrath; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin.

Authors:  D Walmrath; H A Ghofrani; S Rosseau; H Schütte; A Cramer; W Kaddus; F Grimminger; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.